Compile Data Set for Download or QSAR
Report error Found 9 of affinity data for UniProtKB/TrEMBL: Q8N6R3
TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)
Affinity DataKi:  1nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM35254(CHEMBL715 | 2-methyl-4-(4-methylpiperazin-1-yl)-10...)
Affinity DataKi:  2nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50095890(2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-...)
Affinity DataKi:  10nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001885(3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin...)
Affinity DataKi:  14nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50048803(5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-et...)
Affinity DataKi:  15nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50130293(7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}...)
Affinity DataKi:  28nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50652792(CHEMBL3752910)
Affinity DataKd:  753nMAssay Description:Binding affinity to human H1F0 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi:  780nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50652793(CHEMBL5653589)
Affinity DataKd:  1.29E+3nMAssay Description:Binding affinity to human H1F0 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed